BioCentury | Oct 15, 2020
Product Development
Oct. 14 Quick Takes: FDA approves first Ebola therapy; plus Vertex tumbles after hours on AAT discontinuation
...round led by Northpond Ventures and Octopus Ventures. Existing investors Amadeus Capital Partners, Delin Ventures and Kindred Capital...
